These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8332846)

  • 1. Variability of the calcium ion activity with pH in stone-forming and non-stone-forming urine.
    Thode J; Holgersen RB; Gerstenberg T
    Scand J Clin Lab Invest Suppl; 1993; 214():121-6. PubMed ID: 8332846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary risk factors for recurrent calcium stone formation in Thai stone formers.
    Stitchantrakul W; Kochakarn W; Ruangraksa C; Domrongkitchaiporn S
    J Med Assoc Thai; 2007 Apr; 90(4):688-98. PubMed ID: 17487123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Calcium concentrations in the urine of recurrent stone-formers and their controls (author's transl)].
    Leskovar P; Hartung R; Siebert A; Wellnhofer E
    Urologe A; 1980 Jul; 19(4):207-13. PubMed ID: 7414765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary magnesium and its relationship to calcium in recurrent stone-formers and controls (author's transl)].
    Leskovar P; Hartung R; Siebert A; Wellnhofer E
    Urologe A; 1980 Jul; 19(4):214-9. PubMed ID: 7414766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of acute acid loading on acid-base and calcium metabolism.
    Osther PJ
    Scand J Urol Nephrol; 2006; 40(1):35-44. PubMed ID: 16452054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simplified protocol for biochemical evaluation of recurrent renal calcium stone disease.
    Thode J; Finnerup B; Parvin C; Holmegaard SN; Skaarup P; Sørensen OH; Transbøl I
    Miner Electrolyte Metab; 1988; 14(5):288-96. PubMed ID: 2845241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance and low urinary citrate excretion in calcium stone formers.
    Cupisti A; Meola M; D'Alessandro C; Bernabini G; Pasquali E; Carpi A; Barsotti G
    Biomed Pharmacother; 2007 Jan; 61(1):86-90. PubMed ID: 17184967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The urinary response to an oral oxalate load in recurrent calcium stone formers.
    Krishnamurthy MS; Hruska KA; Chandhoke PS
    J Urol; 2003 Jun; 169(6):2030-3. PubMed ID: 12771711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citric acid or citrates in urine: which should we focus on in the prevention of calcium oxalate crystals and stones?
    Laube N; Jansen B; Hesse A
    Urol Res; 2002 Oct; 30(5):336-41. PubMed ID: 12389124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why does the Bonn Risk Index discriminate between calcium oxalate stone formers and healthy controls?
    Kavanagh JP; Laube N
    J Urol; 2006 Feb; 175(2):766-70. PubMed ID: 16407047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of pH on urinary ionized [Ca2+]: differences between urinary tract stone formers and normal subjects.
    Langley SE; Fry CH
    Br J Urol; 1997 Jan; 79(1):8-14. PubMed ID: 9043487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for biochemical abnormalities in urolithiasis patients.
    Orakzai N; Hanbury DC; Farrington K
    J Ayub Med Coll Abbottabad; 2004; 16(2):60-3. PubMed ID: 15455621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of urine pH in the occurrence of phosphaturia].
    Tozuka K; Hara Y; Moriguchi H; Kikuchi T; Tokue A
    Hinyokika Kiyo; 1989 Sep; 35(9):1475-8. PubMed ID: 2816612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients.
    Siener R; Schade N; Nicolay C; von Unruh GE; Hesse A
    J Urol; 2005 May; 173(5):1601-5. PubMed ID: 15821507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary stone risk factors in the siblings of patients with calcium renal stones.
    Kinder JM; Clark CD; Coe BJ; Asplin JR; Parks JH; Coe FL
    J Urol; 2002 May; 167(5):1965-7. PubMed ID: 11956418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary metabolic evaluations in solitary and recurrent stone forming children.
    DeFoor W; Minevich E; Jackson E; Reddy P; Clark C; Sheldon C; Asplin J
    J Urol; 2008 Jun; 179(6):2369-72. PubMed ID: 18433777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the free Ca2+ in undiluted urine from stone formers and normal subjects using a new generation of ion-selective electrodes.
    Langley SE; Fry CH
    Br J Urol; 1995 Mar; 75(3):288-95. PubMed ID: 7735795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers.
    Massey LK; Sutton RA
    J Urol; 2004 Aug; 172(2):555-8. PubMed ID: 15247728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stone forming risk of calcium citrate supplementation in healthy postmenopausal women.
    Sakhaee K; Poindexter JR; Griffith CS; Pak CY
    J Urol; 2004 Sep; 172(3):958-61. PubMed ID: 15311008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.